Home

Allergie Boykott kühl viatris diabetes Gebühr Zurückrufen Herzogin

Lernmodule zu Diabetes mellitus
Lernmodule zu Diabetes mellitus

CMI Metformin Viatris
CMI Metformin Viatris

Lernmodule zu Diabetes mellitus
Lernmodule zu Diabetes mellitus

Pressemitteilung: Welt-Thrombose-Tag – Viatris setzt sich ein, für Risiken  und ... | Presseportal
Pressemitteilung: Welt-Thrombose-Tag – Viatris setzt sich ein, für Risiken und ... | Presseportal

Lernmodule zu Diabetes mellitus
Lernmodule zu Diabetes mellitus

Viatris | CME-Module: Diabetes und seine Facetten - Randindikationen für  Insulin
Viatris | CME-Module: Diabetes und seine Facetten - Randindikationen für Insulin

Biocon Biologics, Viatris gets European Commission nod for co-developed  diabetes drug - The Hindu BusinessLine
Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug - The Hindu BusinessLine

Biocon Biologics, Viatris gets European Commission nod for co-developed  diabetes drug Business
Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug Business

Unser Anliegen | Viatris
Unser Anliegen | Viatris

Produkte | Viatris
Produkte | Viatris

Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE  (insulin glargine-yfgn) Injection and Insulin Glargine (insulin  glargine-yfgn) Injection - Healthcare Radius
Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - Healthcare Radius

Viatris Recalls One Batch Of Diabetes Treatment Semglee Citing Missing  Label Risks
Viatris Recalls One Batch Of Diabetes Treatment Semglee Citing Missing Label Risks

Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu  Entwicklung, ... | Presseportal
Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu Entwicklung, ... | Presseportal

Biocon Biologics, Viatris Gets European Commission Nod For Co-Developed  Diabetes Drug
Biocon Biologics, Viatris Gets European Commission Nod For Co-Developed Diabetes Drug

Lernmodule zu Diabetes mellitus
Lernmodule zu Diabetes mellitus

Featured Stories | Viatris
Featured Stories | Viatris

Biocon, Viatris get USFDA's nod for interchangeable biosimilar product -  The Hindu BusinessLine
Biocon, Viatris get USFDA's nod for interchangeable biosimilar product - The Hindu BusinessLine

Biocon Biologics and Viatris launch interchangeable Semglee - Express Pharma
Biocon Biologics and Viatris launch interchangeable Semglee - Express Pharma

Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu  Entwicklung, ... | Presseportal
Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu Entwicklung, ... | Presseportal

Biocon subsidiary acquires Viatris pharma for $3 billion | Mint
Biocon subsidiary acquires Viatris pharma for $3 billion | Mint

Viatris on LinkedIn: #dyk #worlddiabetesday
Viatris on LinkedIn: #dyk #worlddiabetesday

Viatris Inc. and Biocon Biologics Receive Historic Approval for First  Interchangeable Biosimilar Semglee® (insulin glargine-yfgn) injection for  the Treatment of Diabetes
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn) injection for the Treatment of Diabetes

The Evolving Landscape of Diabetes Care: Technological Advances to  Biosimilars - European Medical Journal
The Evolving Landscape of Diabetes Care: Technological Advances to Biosimilars - European Medical Journal